Search Results

You are looking at 271 - 280 of 524 items for :

  • "Adjuvant therapy" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Multigene Testing in Localized Prostate Cancer

Ashley E. Ross

. 10. Klein EA Yousefi K Haddad Z . A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy . Eur

Full access

Novel Approaches to Advanced Breast Cancer: Bevacizumab and Lapatinib

Erica L. Mayer, Nancy U. Lin, and Harold J. Burstein

Yothers G Romond E . Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2

Full access

Chemotherapy in the Management of Osteosarcoma and Ewing's Sarcoma

Scott M. Schuetze

. Adjuvant therapy of osteosarcoma—a phase II trial: Southwest Oncology Group study 9139 . Cancer 2004 ; 100 : 818 – 825 . 33. Voute PA Souhami RL Nooij M . A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial

Full access

The Role of Radiation Treatment in the Contemporary Management of Bone Tumors

Borislav Hristov, Ori Shokek, and Deborah A. Frassica

curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orth Rel Res 2005 ; 435 : 211 – 218 . 49. Chen ZX Gu DZ Yu ZH . Radiation therapy of giant cell tumor of bone: analysis of 35 patients . Int J

Full access

Immune-Related Adverse Events Among COVID-19–Vaccinated Patients With Cancer Receiving Immune Checkpoint Blockade

Adam J. Widman, Bevin Cohen, Vivian Park, Tara McClure, Jedd Wolchok, and Mini Kamboj

For example, a recent study of pembrolizumab as adjuvant therapy in 509 patients with resected stage III melanoma found an irAE incidence of 19% within 3 months of treatment initiation 6 ; most irAEs were mild. No differences were observed in the risk

Full access

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

Masumi Ueda, Renato Martins, Paul C. Hendrie, Terry McDonnell, Jennie R. Crews, Tracy L. Wong, Brittany McCreery, Barbara Jagels, Aaron Crane, David R. Byrd, Steven A. Pergam, Nancy E. Davidson, Catherine Liu, and F. Marc Stewart

patients, adjuvant therapy with curative intent likely should proceed, despite the threat of COVID-19 infection during treatment. For patients with metastatic disease, treatment delays may lead to worsening performance status and loss of the window to treat

Full access

The Role of Inhibitors of the Epidermal Growth Factor in Management of Head and Neck Cancer

Bruce Brockstein, Mario Lacouture, and Mark Agulnik

Edited by Kerrin G. Robinson

(CRT) followed by G adjuvant therapy for locally advanced head and neck cancer (HNC) [abstract] . J Clin Oncol 2007 ; 25 ( Suppl 1 ): Abstract 6028 . 59. Herchenhorn D Dias FL Pineda RM . Phase II study of erlotinib combined with

Full access

Ovarian Cancer Biomarkers: Current Options and Future Promise

Christine M. Coticchia, Jiang Yang, and Marsha A. Moses

Group experience . J Clin Oncol 1991 ; 9 : 1138 – 1150 . 6. Young RC Walton LA Ellenberg SS . Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials . N Engl J Med 1990 ; 322

Full access

Modification and Implementation of NCCN Guidelines™ on Hepatobiliary Cancers in the Middle East and North Africa Region

Muhammed Aasim Yusuf, Vinay Kumar Kapoor, Refaat Refaat Kamel, Ather Kazmi, Najam Uddin, Nehal Masood, and Abdulmajeed Al-Abdulkareem

hepatocellular carcinoma . Liver Transpl 2005 ; 11 : 1086 – 1092 . 14. Llovet JM Mas X Aponte JJ . Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation . Gut 2002 ; 50 : 123 – 128

Full access

Merkel Cell Carcinoma: A Review of Current Advances

Frank Qian Zhan, Vathani Sharon Packianathan, and Nathalie Charlotte Zeitouni

Oncol 2007 ; 25 : 1043 – 1047 . 71 Garneski KM Nghiem P . Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy . J Am Acad Dermatol 2007 ; 57 : 166 – 169 .